Kivo

Name: Kivo
Brand: Kivo
Rating: 4.9 (21 reviews)

AI Native

Regulated Content Management for Emerging Life Sciences

Est 2021|Valuation $13.5M|Raised $12.8M

LinkedIn 2K|Web traffic 8K|FTEs 44|HQ Portland, Oregon, US

01Competitive Landscape

Narrative analysis

Kivo is positioned in vendor materials and community commentary as a lower-friction option relative to some incumbents, with emphasis on a modern interface and shorter implementations. Public review samples skew toward smaller organizations.
Veeva is commonly cited as a large-enterprise incumbent with extensive ecosystem integrations and broad adoption in large pharma.
MasterControl and other established QMS vendors have larger public reference sets and longer enterprise histories in many evaluations.

- Kivo is positioned in vendor materials and community commentary as a lower-friction option relative to some incumbents, with emphasis on a modern interface and shorter implementations. Public review samples skew toward smaller organizations. - Veeva is commonly cited as a large-enterprise incumbent with extensive ecosystem integrations and broad adoption in large pharma. - MasterControl and other established QMS vendors have larger public reference sets and longer enterprise histories in many evaluations.

	Kivo	Veeva Vault	MasterControl Quality Excellence
Starting Price	Not publicly published; contact vendor for a quote. Some third-party captures referenced historical plan-level figures but these are unverified.	Quote-based, multi-module enterprise pricing; typically positioned at the higher end for multi-module deployments.	Reported starting price varies by source; quotes are typically required and enterprise pricing is common.
Best For	Emerging and mid-market life sciences organizations seeking a unified, compliant workspace with shorter rollout times.	Large enterprises requiring a broad platform ecosystem and deep suite integration.	Mid to large life sciences organizations requiring a mature QMS platform with enterprise usage and validation history.
Key Strength	Usability, vendor statements about short implementation timelines, bundled modules (RIM/eTMF/QMS), and vendor pricing constructs that aim to reduce per-unit charges.	Enterprise ecosystem depth and broad adoption in large pharma.	QMS maturity, established enterprise workflows, and a large installed base.
Key Weakness	Smaller public review footprint and fewer publicly documented large-enterprise deployments.	Cost and implementation complexity cited by some customers.	Perceptions of complexity and administrative overhead for some customers.

Kivo

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map